R.Veatch, “Transplanting Hearts after Death Measured by Cardiac Criteria: The Challenge to the Dead Donor Rule,”Journal of Medicine and Philosophy35, no. 3 (2010): 313-329; S. J. Youngner et al., “Ethical, Psychosocial, and Public Policy Implications of Procuring Organs from Non — Heart-Beating Cadaver Donors,” Journal of the American Medical Association 269, no. 21 (1993): 2769-2774; J. Menikoff, “The Importance of Being Dead: Non-Heart-Beating Organ Donation,” Issues in Law and Medicine 18, no. 1 (2002): 3-20; Institute of Medicine, Non-Heart-Beating Organ Transplantation: Medical and Ethical Issues in Procurement (Washington, DC: National Academies Press, 1997); Institute of Medicine, Non-Heart-Beating Organ Transplantation: Practice and Protocols (Washington, DC: National Academies Press, 2000); J.M. DuBois et al., “When Organ Donors are Still Patients: Is Premortem Use of Heparin Ethically Acceptable?” American Journal of Critical Care 16, no. 4 (2007): 396-400.
2.
Veatch, supra note 1; M.Bouceket al., “Pediatric Heart Transplantation after Declaration of Cardiocirculatory Death,”New England Journal of Medicine359, no. 7 (2008): 709-714; R.D. Truog et al., “The Dead Donor Rule and Organ Transplantation,” New England Journal of Medicine 359, no. 7 (2008): 674-675; J.L. Bernat, “The Boundaries of Organ Donation after Circulatory Death,” New England Journal of Medicine 359, no. 7 (2008): 669-671; R.M. Veatch, “Donating Hearts after Cardiac Death — Reversing the Irreversible,” New England Journal of Medicine 359, no. 7 (2008): 672-673.
3.
Veatch 2008, supra note 2; J.LBernat, “How the Distinction between ‘Irreversible’ and ‘Permanent’ Illuminates Circulatory–Respiratory Death Determination,”Journal of Medicine and Philosophy35, no. 3 (2010): 242-255; Uniform Determination of Death Act 1980, USA.
4.
L.F.Ross and J. R.Thistlethwaite, “Living Donation by Individuals with Life-Limiting Conditions,”Journal of Law, Medicine & Ethics47, no. 1 (2019): 112-122.
5.
K.K.Clemenset al., “Psychosocial Health of Living Kidney Donors: A Systematic Review,”American Journal of Transplantation6, no. 12 (2006): 2965-2977; M.A. Dew et al., “Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL),” Transplantation 100, no. 6 (2016): 1257-1269.
6.
Ross and Thistlethwaite, supra note 4.
7.
M.J.Cherry, “Organ Vouchers and Barter Markets: Saving Lives, Reducing Suffering, and Trading in Human Organs,”Journal of Medicine and Philosophy42, no. 5 (2017): 503-517; L.F. Ross et al., “Ethical and Logistical Issues Raised by the Advanced Donation Program ‘Pay it Forward’ Scheme,” Journal of Medicine and Philosophy, 42, no. 5 (2017): 518-536; S.J. Kerstein, “Kidney Vouchers and Inequity in Transplantation,” Journal of Medicine and Philosophy 42, no. 5 (2017): 559-574; J.J. Koplin, “The Body as Gift, Commodity, or Something in Between: Ethical Implications of Advanced Kidney Donation,” Journal of Medicine and Philosophy 42, no. 5 (2017): 575-596; J. S. Taylor, “From Directed Donation to Kidney Sale: Does the Argument Hold Up?” Journal of Medicine and Philosophy 42, no. 5 (2017): 597-614.
8.
Ross and Thisthlewaite, supra note 4.
9.
D. A.Shewmon, “Constructing the Death Elephant: A Synthetic Paradigm Shift for the Definition, Criteria, and Tests for Death,”Journal of Medicine and Philosophy35, no. 3 (2010): 256-298; S.K. Shah and F.G. Miller, “Can We Handle the Truth? Legal Fictions in the Determination of Death,” American Journal of Law & Medicine 36, no. 4 (2010): 540-585; S.K. Shah, “Piercing the Veil: The Limits of Brain Death as a Legal Fiction,” University of Michigan Journal of Law Reform 48 (2014): 301-346; R. M. Veatch, “Killing by Organ Procurement: Brain-Based Death and Legal Fictions,” Journal of Medicine and Philosophy 40, no. 3 (2015): 289-311; R.D. Truog and J.C. Fackler, “Rethinking Brain Death,” Critical Care Medicine 20, no. 12 (1992): 1705-1713; N. Fost, “Reconsidering the Dead Donor Rule: Is it Important that Organ Donors be Dead?” Kennedy Institute of Ethics Journal 14, no. 3 (2004): 249-260; M.L. Condic, “Determination of Death: A Scientific Perspective on Biological Integration,” Journal of Medicine and Philosophy 41, no. 3 (2016): 257-278; D.A. Shewmon, “The Brain and Somatic Integration: Insights into the Standard Biological Rationale for Equating ‘Brain Death’ with Death,” Journal of Medicine and Philosophy 26 (2001): 457–478; E.C. Brugger, “Are Brain Dead Individuals Dead? Grounds for Reasonable Doubt,” Journal of Medicine and Philosophy 41, no. 3 (2016): 329-350; M. Collins, “Reevaluating the Dead Donor Rule,” Journal of Medicine and Philosophy 35, no. 2 (2010): 154-179.
10.
G.Khushf, “A Matter of Respect: A Defense of the Dead Donor Rule and of a ‘Whole-Brain’ Criterion for Determination of Death,”Journal of Medicine and Philosophy35, no. 3 (2010): 330-364; F.G. Miller and R. D. Truog, Death, Dying, and Organ Transplantation: Reconstructing Medical Ethics at the End of Life (New York: Oxford University Press, 2011).
11.
D.Wilkinson and J.Savulescu, “Should We Allow Organ Donation Euthanasia? Alternatives for Maximizing the Number and Quality of Organs for Transplantation,”Bioethics26, no. 1 (2012): 32-48; J. A.M. Bollen et al., “Euthanasia through Living Organ Donation: Ethical, Legal and Medical Challenges,” Journal of Heart and Lung Transplantation 38, no. 2 (2019): 111-113.
12.
Ross and Thistlethwaite, supra note 4.
13.
M.Nair-Collinset al., “Abandoning the Dead Donor Rule? A National Survey of Public Views on Death and Organ Donation,”Journal of Medical Ethics41 (2015): 297-302.
